https://www.pharmaceutical-technology.com/data-insights/bolt-biotherapeutics-files-patent-for-immunoconjugates-for-cancer-treatment-using-elastase-substrate-peptide-linker/
Discover a groundbreaking immunoconjugate patent by Bolt Biotherapeutics Inc. that revolutionizes cancer treatment. Learn about the cell-binding agent and...
cancer treatmentboltbiotherapeuticsincimmunoconjugates